InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Discover the full record of transactions filed by Miller Peter K, Chairman & CEO. Director active across 1 companies, notably OptiNose, Inc.. Aggregated, 10 filings have been published. Total volume traded: €61k. The latest transaction was filed on 15 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
086,800 shares0
Common Stock
SEC:0001494650-22-000085:0·
€49,96225,974 shares@ €1.923566.5% of flow
Common Stock
SEC:0001494650-22-000025:0·
0215,500 shares0
Common Stock
SEC:0001494650-22-000002·
0215,500 shares0
Common Stock
SEC:0001494650-22-000002:0·
€5,4823,774 shares@ €1.452543.6% of flow
Common Stock
SEC:0001494650-21-000157·
€5,4823,774 shares@ €1.45257.3% of flow
Common Stock
SEC:0001494650-21-000157:0·
79,508 shares
Common Stock
SEC:0001494650-21-000112·
79,508 shares
Common Stock
SEC:0001494650-21-000112:0·
€7,0812,290 shares@ €3.092356.4% of flow
Common Stock
SEC:0001494650-21-000080·
€7,0812,290 shares@ €3.09239.4% of flow
Common Stock
SEC:0001494650-21-000080:0·
10 of 10 declarations
About Miller Peter K
Peter K. Miller is the President and CEO of OptiNose, Inc. He leads the company by implementing strategies aimed at improving performance and fostering innovation in the healthcare sector.
